|
Register: Official Launch of the VERSE Equity Toolkit For Multidimensional Equity Assessments
Join us for the official launch of the Vaccine Economics Research for Sustainability and Equity (VERSE) Equity Toolkit, which compares the level of vaccine coverage against the level of equity and quantifies the influence of key sociodemographic factors to inequity. The toolkit uses novel methodologies to rank a country’s population by level of composite disadvantage which is composed of known factors that fairly and unfairly influence access to and uptake of vaccines. IVAC's health economist, Dr. Bryan Patenaude, and fellow economist, Dr. Elizabeth Ekirapa Kiracho, at Makerere University, Uganda will discuss the development, uses, and policy implications of the toolkit. Access the toolkit. |
|
Highlights from World Immunization Week 2022 |
|
|
|
Watch Webinars from World Immunization Week 2022 IVAC along with global immunization and Indigenous health partners, hosted three webinars. Recordings are available and free to view on our YouTube channel. Share Messages about #LongLifeForAll Continue promoting the value of vaccines by sharing these social media messages. View our toolkit here. |
|
Vaccine News and Resources |
|
|
Rotavirus Vaccine Series of Briefs—Newly Updated
Six rotavirus-focused briefs, produced by the ROTA Alliance, cover epidemiology and disease burden, available vaccine products, the impact of vaccination, economic costs of rotavirus disease and the value of vaccines, safety, and introduction and coverage status. The Council’s series also includes a supplemental brief on the broad impact of early childhood diarrhea.
|
|
|
#ICYMI: VARN2022 Conference Session Recordings
For those unable to attend, the Sabin Vaccine Institute and its Vaccination Acceptance Research Network (VARN) Conference recorded these engaging sessions, which are available to watch for free online. IVAC presented during the following sessions:
|
|
|
Study Finds That Children’s Antibody Responses to COVID-19 Are Stronger Than Adults’
A new study suggests that children tend to have strong antibody responses after SARS-CoV-2 infection. Understanding antibody responses to SARS-CoV-2 at different ages can inform COVID-19 vaccine strategies and policies. The findings are published in JCI Insight.
|
|
|
IVAC and VALUE Baltimore Project Launch COVID-19 Information Compendium
The VALUE (Vaccine Acceptance & Access Live in Unity, Engagement, and Education) Baltimore Project, which aims to improve COVID-19 vaccine acceptance in Baltimore City, has created a new resource for anyone seeking up-to-date information about COVID-19. The Compendium of Information on COVID-19 Vaccination and Communications is a living document that is continuously updated with new COVID-19 information and policy.
|
|
|
Katherine L. O'Brien Awarded Jimmy and Rosalynn Carter Humanitarian Award Dr. Katherine O'Brien, IVAC's former executive director, was awarded the prestigious 2022 Rosalyn and Jimmy Carter Humanitarian Award by the National Foundation for Infectious Diseases for her career contributions to global vaccine equity. View all recipients here. |
|
|
Rubella By Amy Winter and William Moss In a seminar on rubella published in The Lancet, the authors describe in-depth rubella's epidemiology, virology, diagnosis, management, and elimination. While the timeline for eradicating rubella is uncertain, reducing its burden is promising with current rubella vaccines. New technologies like microarray patches could make it even easier to vaccinate hard-to-reach populations like zero-dose children. |
|
|
|
|
|
|